Literature DB >> 18931654

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Trond Aasen1, Angel Raya, Maria J Barrero, Elena Garreta, Antonella Consiglio, Federico Gonzalez, Rita Vassena, Josipa Bilić, Vladimir Pekarik, Gustavo Tiscornia, Michael Edel, Stéphanie Boué, Juan Carlos Izpisúa Belmonte.   

Abstract

The utility of induced pluripotent stem (iPS) cells for investigating the molecular logic of pluripotency and for eventual clinical application is limited by the low efficiency of current methods for reprogramming. Here we show that reprogramming of juvenile human primary keratinocytes by retroviral transduction with OCT4, SOX2, KLF4 and c-MYC is at least 100-fold more efficient and twofold faster compared with reprogramming of human fibroblasts. Keratinocyte-derived iPS (KiPS) cells appear indistinguishable from human embryonic stem cells in colony morphology, growth properties, expression of pluripotency-associated transcription factors and surface markers, global gene expression profiles and differentiation potential in vitro and in vivo. To underscore the efficiency and practicability of this technology, we generated KiPS cells from single adult human hairs. Our findings provide an experimental model for investigating the bases of cellular reprogramming and highlight potential advantages of using keratinocytes to generate patient-specific iPS cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931654     DOI: 10.1038/nbt.1503

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  534 in total

Review 1.  Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Authors:  Kenneth R Boheler
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

Review 2.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

3.  Generation of induced pluripotent stem cells from urine.

Authors:  Ting Zhou; Christina Benda; Sarah Duzinger; Yinghua Huang; Xingyan Li; Yanhua Li; Xiangpeng Guo; Guokun Cao; Shen Chen; Lili Hao; Yau-Chi Chan; Kwong-Man Ng; Jenny Cy Ho; Matthias Wieser; Jiayan Wu; Heinz Redl; Hung-Fat Tse; Johannes Grillari; Regina Grillari-Voglauer; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 4.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells.

Authors:  Gustavo Tiscornia; Erica Lorenzo Vivas; Juan Carlos Izpisúa Belmonte
Journal:  Nat Med       Date:  2011-12       Impact factor: 53.440

Review 5.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 6.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

7.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

8.  Ca2+ activated K channels-new tools to induce cardiac commitment from pluripotent stem cells in mice and men.

Authors:  Martin Müller; Marianne Stockmann; Daniela Malan; Anne Wolheim; Michael Tischendorf; Leonhard Linta; Sarah-Fee Katz; Qiong Lin; Stephan Latz; Cornelia Brunner; Anna M Wobus; Martin Zenke; Maria Wartenberg; Tobias M Boeckers; Götz von Wichert; Bernd K Fleischmann; Stefan Liebau; Alexander Kleger
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 9.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.